文献速递糖尿病肥胖与代谢综合征

SUCNR1介导的巨噬细胞趋化加重肥胖诱导的炎症和糖尿病

SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes.
PubMed 文献 · Diabetologia · 2017-04-05

研究探讨琥珀酸受体1(SUCNR1)在肥胖诱导的脂肪组织炎症和2型糖尿病中的作用。2型糖尿病患者血浆琥珀酸水平较非糖尿病者高53%(p<0.01)。高脂饮食下Sucnr1-/-小鼠脂肪组织巨噬细胞和冠状结构减少、糖耐量改善,巨噬细胞趋化性降低59%(p<0.05)。结果提示SUCNR1是肥胖诱导2型糖尿病的有前景的治疗靶点。

要点

  • 2型糖尿病患者血浆琥珀酸水平较非糖尿病者高53%(p<0.01)。
  • 高脂饮食下Sucnr1-/-小鼠脂肪组织巨噬细胞和冠状结构显著减少,糖耐量显著改善(p<0.001)。
  • Sucnr1-/-小鼠巨噬细胞对凋亡和缺氧脂肪细胞条件培养基的趋化性降低59%(p<0.05)。

核心结论

  • 巨噬细胞中SUCNR1的激活对肥胖时脂肪组织浸润和炎症重要,提示SUCNR1是肥胖诱导2型糖尿病的有前景的治疗靶点。

研究设计与样本

  • 测定2型糖尿病和非糖尿病参与者血浆琥珀酸水平及脂肪组织外植体琥珀酸释放。
  • Sucnr1-/-和野生型同窝小鼠分别给予高脂饮食或低脂饮食16周,检测血清代谢变量、脂肪组织炎症、巨噬细胞迁移和糖耐量。

主要发现

  • 缺氧和高血糖分别独立驱动小鼠脂肪组织释放琥珀酸17倍和高达18倍。
  • 2型糖尿病患者血浆琥珀酸水平较非糖尿病者高53%(p<0.01)。
  • 高脂饮食下Sucnr1-/-小鼠脂肪组织巨噬细胞数为0.56±0.07 vs 野生型0.92±0.15 F4/80细胞/脂肪细胞(p<0.05),冠状结构为0.06±0.02 vs 0.14±0.02 CLS/脂肪细胞(p<0.01)。
  • 高脂饮食下Sucnr1-/-小鼠糖耐量较野生型显著改善(p<0.001),体重增加相似。
  • Sucnr1-/-小鼠巨噬细胞对凋亡和缺氧脂肪细胞条件培养基的趋化性降低59%(p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Obesity induces macrophages to drive inflammation in adipose tissue, a crucial step towards the development of type 2 diabetes. The tricarboxylic acid (TCA) cycle intermediate succinate is released from cells under metabolic stress and has recently emerged as a metabolic signal induced by proinflammatory stimuli. We therefore investigated whether succinate receptor 1 (SUCNR1) could play a role in the development of adipose tissue inflammation and type 2 diabetes. METHODS: Succinate levels were determined in human plasma samples from individuals with type 2 diabetes and non-diabetic participants. Succinate release from adipose tissue explants was studied. Sucnr1 -/- and wild-type (WT) littermate mice were fed a high-fat diet (HFD) or low-fat diet (LFD) for 16 weeks. Serum metabolic variables, adipose tissue inflammation, macrophage migration and glucose tolerance were determined. RESULTS: We show that hypoxia and hyperglycaemia independently drive the release of succinate from mouse adipose tissue (17-fold and up to 18-fold, respectively) and that plasma levels of succinate were higher in participants with type 2 diabetes compared with non-diabetic individuals (+53%; p < 0.01). Sucnr1 -/- mice had significantly reduced numbers of macrophages (0.56 ± 0.07 vs 0.92 ± 0.15 F4/80 cells/adipocytes, p < 0.05) and crown-like structures (0.06 ± 0.02 vs 0.14 ± 0.02, CLS/adipocytes p < 0.01) in adipose tissue and significantly improved glucose tolerance (p < 0.001) compared with WT mice fed an HFD, despite similarly increased body weights. Consistently, macrophages from Sucnr1 -/- mice showed reduced chemotaxis towards medium collected from apoptotic and hypoxic adipocytes (-59%; p < 0.05). CONCLUSIONS/INTERPRETATION: Our results reveal that activation of SUCNR1 in macrophages is important for both infiltration and inflammation of adipose tissue in obesity, and suggest that SUCNR1 is a promising therapeutic target in obesity-induced type 2 diabetes. DATA AVAILABILITY: The dataset generated and analysed during the current study is available in GEO with the accession number GSE64104, www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64104 .

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. van Diepen JA, Robben JH, Hooiveld GJ, et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia. 2017. PMID: 28382382. doi:10.1007/s00125-017-4261-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。